Name	Info	Provider	Link
	subscription/membership/fee required	Elsevier Science	https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(22)00506-0
COVID-19 (Coronavirus Disease 2019)	free resource	MedlinePlus Health Information	https://medlineplus.gov/covid19coronavirusdisease2019.html
	free resource	PubMed Central	https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36113538/
	free resource	Europe PubMed Central	https://europepmc.org/abstract/MED/36113538
	free resource	NCI CPTC Antibody Characterization Program	https://antibodies.cancer.gov/detail/CPTC-GST+Mu1-6
	free resource	NCI CPTAC Assay Portal	https://assays.cancer.gov/CPTAC-438
	subscription/membership/fee required	ClinicalKey	https://www.clinicalkey.com/content/playBy/pii?v=S1473-3099(22)00506-0
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older	free resource	The YODA Project	https://yoda.yale.edu/clinical-trial/nct04614948-a-randomized-double-blind-placebo-controlled-phase-3-study-to-assess-the-efficacy-and-safety-of-ad26-cov2-s-for-the-prevention-of-sars-cov-2-mediated-covid-19-in-adults-aged-18-years-a/